Planet Microcap Podcast | Microcap Investing Strategies
Zomedica (NYSE American: ZOM): Veterinary Health Therapeutic and Diagnostic Products for Companion Animals [Due Diligence Podcast]
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:50:47
- Mas informaciones
Informações:
Sinopsis
My guest on the show today is Larry Heaton, CEO of Zomedica (NYSE American: ZOM), a veterinary health company creating therapeutic and diagnostic products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment of various musculoskeletal issues, such as broken bones, tendonitis, and torn ligaments in horses and small animals. Zomedica has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for development and markets a novel pathogen detection system. According to a 2018 research report by Grand View Research, "The global pet care market size was estimated at USD 131.7 billion in 2016 and is expected to grow with a CAGR of 4.9% from 2016 to 2025." Furthermore, a 2021 ASPCA report no